Behavior of clebopride in experimental models of anxiolytic activity
Berga, P.; Beckett, P.R.; Roberts, D.J.
Archivos de Farmacologia y Toxicologia 8(3): 245-250
1982
ISSN/ISBN: 0304-8616 PMID: 6134499 Document Number: 195954
Document emailed within 1 workday
Related Documents
Ankur, J.; Mahesh, R.; Bhatt, S. 2013: Anxiolytic-like effect of etazolate, a type 4 phosphodiesterase inhibitor in experimental models of anxiety Indian Journal of Experimental Biology 51(6): 444-449Bhatt, S.; Mahesh, R.; Devadoss, T.; Jindal, A. 2013: Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety Indian Journal of Experimental Biology 51(7): 510-514
Koyama, T.; Ichikawa, J.; Nakayama, M.; Inoue, T.; Matsubara, R. 1988: Study on experimental models of methamphetamine-induced mental disorders--relationship between rat brain dopamine and changes in behavior Seishin Shinkeigaku Zasshi 90(10): 853-862
Kuwana, Y.; Shiozaki, S.; Kanda, T.; Kurokawa, M.; Koga, K.; Ochi, M.; Ikeda, K.; Kase, H.; Jackson, M.J.; Smith, L.A.; Pearce, R.K.; Jenner, P.G. 1999: Antiparkinsonian activity of adenosine A2A antagonists in experimental models Advances in Neurology 80: 121-123
Alvisi, V.; Onofrio, W.; Intrieri, L.; D'Ambrosi, A. 1987: Medical therapy of gastroesophageal reflux. Evaluation of the activity of clebopride by continuous intraluminal pH measurement Minerva Medica 78(19): 1421-1426
Rolin, O.; Bouanchaud, D.H. 1987: Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice Pathologie-Biologie 35(5 Part 2): 742-745
Yanaura, S.; Abe, Y.; Mineo, K. 1976: Conditioning of emotional behavior originating at the hypothalamus. (2) Effects of drugs on conflict-induced behavior models Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 72(3): 351-361
Dabrowska, K.; Opolski, A.; Wietrzyk, J.; Switala-Jelen, K.; Boratynski, J.; Nasulewicz, A.; Lipinska, L.; Chybicka, A.; Kujawa, M.; Zabel, M.; Dolinska-Krajewska, B.; Piasecki, E.; Weber-Dabrowska, B.; Rybka, J.; Salwa, J.; Wojdat, E.; Nowaczyk, M.; Gorski, A. 2004: Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway Acta Virologica 48(4): 241-248
Herrmann, W.M.; Beach, R.C. 1978: Experimental and clinical findings indicating anxiolytic properties of gestagens Arzneimittel-Forschung 28(8): 1299
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
García Rafanell, J.; Bellés, L.; Forn, J. 1979: Induction of pulmonary thrombosis in mice, rabbits and hamsters by intravenous injection of arachidonic acid. Comparative study of 3 experimental models in vivo and the antithrombotic activity of triflusal Archivos de Farmacologia y Toxicologia 5(3): 193-198
Britton, K.T.; Page, M.; Baldwin, H.; Koob, G.F. 1991: Anxiolytic activity of steroid anesthetic alphaxalone Journal of Pharmacology and Experimental Therapeutics 258(1): 124-129
Krsiak, M.; Sulcova, A.; Donat, P.; Tomasikova, Z.; Dlohozkova, N.; Kosar, E.; Masek, K. 1984: Can social and agonistic interactions be used to detect anxiolytic activity of drugs? Progress in Clinical and Biological Research 167: 93-114
Krsiak, M. 1974: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs Activitas Nervosa Superior 16(4): 241-242
Kossakowski, J.; Krawiecka, M. 2000: Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIII. Derivatives of 1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide Acta Poloniae Pharmaceutica 57 Suppl: 53-56
Kossakowski, J.; Krawiecka, M. 2003: Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XXIV. Derivatives of N-hydroxy-1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide Acta Poloniae Pharmaceutica 60(3): 177-182
Kossakowski, J.; Perliński, M.ła. 2002: Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XXIII. Derivatives of 2'-chlorodibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide Acta Poloniae Pharmaceutica 59(6): 423-427
Kossakowski, J.; Zawadowski, T.; Kuśmierczyk, J. 1998: Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity Acta Poloniae Pharmaceutica 55(4): 315-318
Kossakowski, J.; Jarocka, M. 2000: Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XII. Derivatives of N-hydroxy-1,4-dimethyl-dibenzo[e.h]bicyclo[2.2.2]-octane-2,3-dicarboximide Acta Poloniae Pharmaceutica 57 Suppl: 60-62
Soubrie, P.; Chermat, R.; Poncelet, M.; Simon, P. 1978: Models of inhibition in animal behavior L'Encephale 4(5 Suppl): 503-511